National Down Syndrome Society Establishes Criteria to Evaluate Companies with Non-Invasive Prenatal Diagnostic Tests for Down Syndrome
The National Down Syndrome Society (NDSS) recognizes that many companies, both within the United States and abroad, are developing new noninvasive blood tests that might be able to detect Down syndrome prenatally. The NDSS appreciates that these tests are likely to be safer for pregnant women than the current invasive options of chorionic villus sampling and amniocentesis. However, before these new tests are made commercially available, companies should first meet all of (these) criteria .... read the whole statement detailing the criteria.
The research paper, to be published in the journal Genetics in Medicine, describing the latest trials upon which the release of this test is based is online here (the abstract is free).